Fidaxomicin API Manufacturers | Suppliers | Exporters

TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

U.S.A

About the Company : Transo-Pharm is a licensed distributor of pharmaceutical components for human and veterinary markets. The company supports the full API life cycle, from development to sales, and a...

Transo-Pharm is a licensed distributor of pharmaceutical components for human and veterinary markets. The company supports the full API life cycle, from development to sales, and acts as a sourcing and regulatory marketing agent for API manufacturers. Transo-Pharm assists with DMF setup, GMP consulting, and regulatory activities, supported by a regulatory team, warehouse facilities, proprietary API process IPs, and laboratory partnerships, with offices in Shanghai, Hong Kong, Singapore, and the US. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

02

ChemWerth Inc

U.S.A

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

U.S.A

About the Company : ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships fo...

ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships for product development, compliance, and secure logistics. ChemWerth accesses over 500 APIs and 30 manufacturing facilities across the US, Europe, India, and China, acts as a regulatory agent for 25+ FDA-approved facilities, sells 100+ products, and operates in 38 countries. In 2020, it filed its 500th DMF with the FDA . Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

03

EUROAPI

France

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

France

About the Company : EUROAPI focuses on reinventing active ingredient solutions to sustainably meet the needs of customers and patients worldwide. The company is a leading API player with a portfolio o...

EUROAPI focuses on reinventing active ingredient solutions to sustainably meet the needs of customers and patients worldwide. The company is a leading API player with a portfolio of around 200 products, covering a wide range of technologies and innovative molecules through CDMO activities. Supported by 3,650 employees, strong R&D capabilities, and six manufacturing sites in Europe, EUROAPI delivers high-quality API manufacturing to customers in more than 80 countries. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

04

Rochem International Inc

U.S.A

Suppliers Night Expo

Attending

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

U.S.A

About the Company : Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered i...

Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered in Hauppauge, New York, it operates 16 offices worldwide. Rochem’s operations are fully cGMP compliant and have been audited by the USFDA and several multinational organizations. The company also trains and audits its partners to ensure FDA-compliant technologies and systems. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

05

Shanghai Minbiotech

China

Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

China

About the Company : Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in...

Shanghai Minbiotech is specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

Corporate PDF

06

TAPI Technology & API Services

Israel

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Israel

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...

Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios with over 350 products, alongside tailored CDMO services. Leveraging deep expertise and diverse technologies, we deliver flexible, high-quality solutions to meet our partners’ needs. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.

07

Apino Pharma

China

BIO Partnering at JPM

Not Confirmed

08

Concord Biotech

India

BIO Partnering at JPM

Not Confirmed

09

Livzon Group Fuzhou Fuxing Pharmace...

China

BIO Partnering at JPM

Not Confirmed

Livzon Group Fuzhou Fuxing Pharmace...

China

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

China

Digital Content

Lipiarmycin

About the Company : Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd(FFPC),a subsidiary of Livzon Pharmaceutical Group Inc.,was founded in 1989 as a state-owned company.Now Livzon Fuxing has become a...

Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd(FFPC),a subsidiary of Livzon Pharmaceutical Group Inc.,was founded in 1989 as a state-owned company.Now Livzon Fuxing has become a big pharmaceutial company,which is focusing on producing API/Intermediate of Antibiotics and food additive. We has two subsidiary plants:Fuqing Jiangyin New Plant and Gutian Fuxing Pharmaceutical Co.,Ltd. Jiangyin Plant is located in Fuqing Jiang Industrial Park, near to Jiangyin port with very convenient transportation. Gutian Plant is located in Huangtian town Gutian county. Our company has advanced production technology and modern production facilities which have been approved with cGMP. In April of 2010,We got EU-GMP for Colistine Sulphate.

Portfolio PDF

Product Web Link

Website

Corporate PDF

10

North China Pharmaceutical Co., Ltd...

China

BIO Partnering at JPM

Not Confirmed

North China Pharmaceutical Co., Ltd...

China

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

China

About the Company : China Pharmaceutical Group is one of China's largest chemical and pharmaceutical companies, located in Shijiazhuang, capital of Hebei Province. North China Pharmaceutical Factory i...

China Pharmaceutical Group is one of China's largest chemical and pharmaceutical companies, located in Shijiazhuang, capital of Hebei Province. North China Pharmaceutical Factory is the predecessor of China " fifteen " key construction project during the 1953 annual six months, started in 1958 in six months to put into operation, creating a history of large-scale production of antibiotics, to change the situation of underserved do an important contribution. 1992 reorganization of the establishment of the North China Pharmaceutical Co., Ltd., 1994 years in the Shanghai Stock Exchange listing. 1996 years 1 month, North China Pharmaceutical formal restructuring of state-owned companies - a North China Pharmaceutical Group Co., Ltd., a complete end to the continuation of decades of the factory system. 2009 On 6 February, the Hebei government approval, Jizhong Energy Group, China Pharmaceutical Group implemented a restructuring, China Pharmaceutical Group to become the world 500 strong enterprises wholly owned subsidiary. Over the years, China Pharmaceutical Group continued innovation, sound management, and gradually expand the business scope continued to expand, maintain good development performance of major economic indicators will always be in the forefront of the industry. As of 2012 end, China Pharmaceutical Group total assets of 158 million yuan, employees 2 million people, with more than forty (minutes), the main products include antibiotics and semi-synthetic antibiotics, biotechnology drugs, biological pesticides and veterinary drugs, vitamins, nutrition and health product formulation 5 series 700 varieties. Put into operation a new cephalosporin, new formulation is representative of the new park projects, marking the opening of the China Pharmaceutical Group to build a leading world-class modern pharmaceutical group's new chapter.

Portfolio PDF

Product Web Link

Website

Corporate PDF

11

Protheragen

U.S.A

BIO Partnering at JPM

Not Confirmed

12

Sajjala Bio Labs

India

BIO Partnering at JPM

Not Confirmed

Sajjala Bio Labs

India

BIO Partnering at JPM

Not Confirmed

Post an Enquiry

India

Digital Content

Lipiarmycin

About the Company : Sajjala Bio Labs is a two year old bio pharmaceutical API production company headquartered in Hyderabad. At the moment, we commercially produce and sell Enoxaparin Sodium and L-asp...

Sajjala Bio Labs is a two year old bio pharmaceutical API production company headquartered in Hyderabad. At the moment, we commercially produce and sell Enoxaparin Sodium and L-asparaginase in the Indian market. Our pipeline of products to be launched in the calendar year 2018 include Liraglutide, Pegylated L-asparaginase, Teriparatide and Hyaluronic Acid. In addition to the production of APIs we also offer a range of R&D services including end-to-end technology transfers and contract product development services. Our infrastructure includes a WHO GMP certifies production facility with 2000 litres fermentation capacity, a DSIR recognised R&D lab, in-house Quality Control facilities and a microbiology lab and all the necessary supporting infrastructure.

Portfolio PDF

Product Web Link